Mark Lebwohl

36PUBLICATIONS
77CO-AUTHORS
Clinical pharmacology and therapeuticsPharmacogenomicsDisease surveillanceAllergyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (36)

|Aug 12, 2026
Effectiveness of brodalumab in biologic-experienced adults with moderate to severe plaque psoriasis: a focused narrative review.

|Aug 07, 2026
Deucravacitinib 5-Year Safety and Efficacy Results in Plaque Psoriasis: A Phase 3 Open-Label Extension of Randomized Clinical Trials.

|Jul 30, 2026
Treatment Patterns, Drug Survival, and Effectiveness of Tildrakizumab Among Patients with Prior Interleukin-17 Experience in the PPD CorEvitas Psoriasis Registry.

|Jul 20, 2026
Nonpruritic Eczematous Flares During Nemolizumab Therapy: A Case Series.

|Jun 02, 2026
Guselkumab Safety in Patients With Latent Tuberculosis: Analysis of 11 Studies in Psoriatic Disease.

|May 08, 2026
The Misdiagnosis of Pemphigus Foliaceus as Psoriasis.

Pageof 6

Frequent Collaborators

8 joint publications

Bruce Strober

4 joint publications

April W Armstrong

4 joint publications

April W Armstrong

4 joint publications

Emma Guttman-Yassky